Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by mousermanon Jul 03, 2013 4:21pm
105 Views
Post# 21587599

New estimate not exciting

New estimate not excitingI dont know what some were expecting here, but this update is subpar. Last resource update from Aurizon last year had 21,670,000 tonnes @ 1.64 gpt AU in indicated ( 1,141,000 ozs) and  4.58 million tonnnes in inferred at 1.79 ( 263,000 ozs). Total was about 1.4 million ozs.
Todays release shows a lot more tonnage and total ozs , about 2.1 million  BUT the average  grades are now lower and the price used to estimate this resource was 1540$ US...
I think had NOX used an average grade of 1.7 gpt AU for the new  estimate nothing much would have changed. They sent a lot of time drilling , and accomplished not a real lot. I dont Hecla will be excited with the result. BUT jmho
<< Previous
Bullboard Posts
Next >>